id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-E-1694-0006,FDA,FDA-2013-E-1694,"Determination of Regulatory Review Period for Purposes of Patent
Extension; Trivascular Ovation Abdominal Stent Graft System",Notice,Determinations,2015-12-15T05:00:00Z,2015,12,2015-12-15T05:00:00Z,2016-02-17T04:59:59Z,2015-12-15T15:20:17Z,2015-31397,0,0,0900006481da72c8
FDA-2013-E-1694-0005,FDA,FDA-2013-E-1694,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-11-09T05:00:00Z,2015,11,2015-11-09T05:00:00Z,,2015-11-30T22:22:02Z,,0,0,0900006481d1d512
FDA-2013-E-1694-0004,FDA,FDA-2013-E-1694,Letter from the U.S. Patent and Trademark Office to FDA,Other,Letter(s),2015-10-26T04:00:00Z,2015,10,2015-10-26T04:00:00Z,,2015-10-26T20:44:05Z,,0,0,0900006481cefa94